MYRG:NASDAQMYR Group, Inc. Analysis
Data as of 2026-05-23 - not real-time
$446.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
MYR Group’s stock is trading well above its short‑term moving average while remaining above the mid‑term average, underscoring a clear bullish trajectory. The long‑term trend line remains firmly below the current price, reinforcing sustained strength. Momentum indicators show an elevated RSI, indicating strong buying pressure. The MACD histogram has turned negative, hinting at a short‑term pullback, but the overall MACD line stays above the signal, supporting continued upside. Recent earnings released this quarter revealed a notable lift in gross margins and operating efficiency, driving investor enthusiasm.
Valuation metrics place the market price just modestly above the discounted cash‑flow estimate, suggesting the stock is fairly priced with limited upside. The company trades at a price‑to‑earnings multiple well above the industry average, reflecting growth expectations rather than pure value. With no dividend payout, income‑focused investors will find the stock unsuitable for yield‑oriented strategies. A beta above the market and heightened recent volatility signal heightened market sensitivity, while decreasing volume adds a modest liquidity concern. Considering the strong operational backdrop, modest valuation premium, and the technical picture, the recommendation leans toward a cautious buy stance for the near term and a hold for longer horizons.
Valuation metrics place the market price just modestly above the discounted cash‑flow estimate, suggesting the stock is fairly priced with limited upside. The company trades at a price‑to‑earnings multiple well above the industry average, reflecting growth expectations rather than pure value. With no dividend payout, income‑focused investors will find the stock unsuitable for yield‑oriented strategies. A beta above the market and heightened recent volatility signal heightened market sensitivity, while decreasing volume adds a modest liquidity concern. Considering the strong operational backdrop, modest valuation premium, and the technical picture, the recommendation leans toward a cautious buy stance for the near term and a hold for longer horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- technical bullish alignment
- margin improvement news
- price near support
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- sustained growth outlook
- fair valuation relative to DCF
- industry tailwinds in clean energy infrastructure
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- elevated valuation relative to peers
- high beta and volatility
- absence of dividend reduces yield appeal
Key Metrics & Analysis
Financial Health
Revenue Growth20.00%
Profit Margin3.71%
P/E Ratio49.3
ROE22.68%
ROA7.56%
Debt/Equity8.75
P/B Ratio9.9
Op. Cash Flow$328.0M
Free Cash Flow$227.8M
Industry P/E29.7
Technical Analysis
TrendBullish
RSI62.4
Support$329.74
Resistance$480.00
MA 20$432.13
MA 50$350.83
MA 200$254.09
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$437.64
Target Price$455.00
Upside/Downside1.81%
GradeFair
TypeGrowth
Risk Assessment
Beta1.74
Volatility68.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.